Anne-Marie Carbonell is the founder of OncoSynergy. OncoSynergy has raised $25M in total funding. Latest round: Series A.
Anne-Marie Carbonell, MD, is the Co-Founder, Chief Executive Officer, and Chief Medical Officer of OncoSynergy, a biopharma startup focused on developing cancer medicines for glioblastoma and acute leukemia. The company was spun out from UCSF and JLABS. She co-founded OncoSynergy with her husband, Dr. Shawn Carbonell, and leads the medical and clinical strategy for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library